Empagliflozin Improves Endothelial Function in an Ovariectomized Rat Model of Estrogen Deficiency
Journal of Cardiovascular Translational Research · 2026-12 · 19 (1)
DOI: 10.1007/s12265-026-10823-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Translational Research, online erschienen am 06.08.2026. Verfasst von Amanina Athirah Mad Azli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, 56000, Malaysia. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Ovariectomy, Glucosides, Vasodilation. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Ministry of Higher Education Malaysia Fundamental Research Grant Scheme.
Abstract (Originalsprache)
Cardiovascular disease risk increases after menopause, largely driven by estrogen deficiency-induced endothelial dysfunction. While sodium-glucose cotransporter 2 (SGLT2) inhibitors confer cardiovascular protection, their vascular effects under estrogen-deficient conditions remain unclear. This study investigated the effects of the SGLT2 inhibitor empagliflozin on vascular function in an ovariectomized (OVX) rat model of estrogen deficiency. Female Sprague-Dawley rats were assigned to control, OVX, OVX + vehicle, OVX + empagliflozin (10 mg/kg/day), and OVX + estradiol (20 µg/kg/day) groups for 28 days. Vascular reactivity was assessed using wire myography, alongside evaluation of endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) levels. OVX rats exhibited impaired endothelium-dependent vasorelaxation, increased vasoconstriction, reduced eNOS activation, and decreased NO bioavailability. Empagliflozin significantly improved vascular reactivity, enhanced eNOS activation, and restored NO levels, with effects comparable to estradiol. These findings identify empagliflozin as a potential non-hormonal therapeutic strategy for endothelial dysfunction in postmenopausal conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, 56000, Malaysia.
- Cardiovascular and Pulmonary (CardioResp) Research Group, Universiti Kebangsaan Malaysia, Bangi, Selangor, 43600, Malaysia.
- Department of Obstetrics & Gynecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, 56000, Malaysia.
- Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, 56000, Malaysia. dr.azizah@hctm.ukm.edu.my.
- Cardiovascular and Pulmonary (CardioResp) Research Group, Universiti Kebangsaan Malaysia, Bangi, Selangor, 43600, Malaysia. dr.azizah@hctm.ukm.edu.my.
ORCID-Profile: Azizah Ugusman
Förderung
- Ministry of Higher Education Malaysia Fundamental Research Grant Scheme
Zitieren
APA
Mad Azli, A. A., Mokhtar, M. H., Aminuddin, A., Hamid, A. A., Kumar, J., Ahmad, M. F., & Ugusman, A. (2026). Empagliflozin Improves Endothelial Function in an Ovariectomized Rat Model of Estrogen Deficiency. Journal of Cardiovascular Translational Research, 19(1). https://doi.org/10.1007/s12265-026-10823-2
Vancouver
Mad Azli AA, Mokhtar MH, Aminuddin A, Hamid AA, Kumar J, Ahmad MF, et al. Empagliflozin Improves Endothelial Function in an Ovariectomized Rat Model of Estrogen Deficiency. Journal of Cardiovascular Translational Research. 2026;19(1). doi:10.1007/s12265-026-10823-2
BibTeX
@article{MadAzli2026,
author = {Mad Azli, Amanina Athirah and Mokhtar, Mohd Helmy and Aminuddin, Amilia and Hamid, Adila A and Kumar, Jaya and Ahmad, Mohd Faizal and Ugusman, Azizah},
title = {Empagliflozin Improves Endothelial Function in an Ovariectomized Rat Model of Estrogen Deficiency},
journal = {Journal of Cardiovascular Translational Research},
year = {2026},
volume = {19},
number = {1},
doi = {10.1007/s12265-026-10823-2}
}
EUVIMED